Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Negative Breast Cancer
100%
Chemokine Receptor CXCR4
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
81%
Overexpression
50%
Tumor
31%
Breast Cancer
18%
Breast Tissue
18%
CXCR4 Expression
18%
Benign Breast
18%
Independent Sample T-test
12%
Tumor Size
12%
Cancer Recurrence
12%
Nodal Status
12%
Overall Survival
6%
Western Blot
6%
Expression Level
6%
Statistical Analysis
6%
Positive Control
6%
Clinical Setting
6%
HeLa Cells
6%
I to
6%
Statistical Significance
6%
Cancer Mortality
6%
Disease-free Survival
6%
Metastatic Breast Cancer
6%
Chemokine Receptor
6%
Human Breast Cancer
6%
Metastatic Disease
6%
Log-rank Test
6%
Breast Cancer Patients
6%
Tumor Recurrence
6%
Spearman Correlation
6%
Prolonged Survival
6%
Clinical Course
6%
Dako
6%
Aggressive Biological Behavior
6%
Standardized Treatment
6%
Disease Survival
6%
Breast Cancer Growth
6%
Model Reduction
6%
Kaplan-Meier Survival Analysis
6%
Medicine and Dentistry
Breast Cancer
100%
Recurrent Disease
100%
Chemokine Receptor CXCR4
100%
Neoplasm
87%
Breast Tissue
37%
Malignant Neoplasm
25%
Student T Test
25%
Metastatic Carcinoma
25%
Cancer Recurrence
25%
Cancer Growth
12%
Overall Survival
12%
Disease Course
12%
Western Blot
12%
Log Rank Test
12%
Cancer Mortality
12%
Tumor Recurrence
12%
Survival Analysis
12%
Protocol Compliance
12%
Disease Free Survival
12%
Chemokine Receptor
12%
Biochemistry, Genetics and Molecular Biology
CXCR4
100%
Chemokine Receptor
100%
Tumor Volume
11%
Animal Model
5%
Overall Survival
5%
Western Blot
5%
Disease Free Survival
5%
Protocol Compliance
5%